# A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention

> **NCT01327183** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 532 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **PROCEDURE:** Percutaneous Coronary Intervention (PCI)
- **DRUG:** RO4905417
- **DRUG:** RO4905417
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01327183
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 532 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327183, "A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01327183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*